RecruitingPhase 2Phase 3NCT05091242

The PREVENT AGITATION Trial II - Children ≤1 Year


Sponsor

Rigshospitalet, Denmark

Enrollment

336 participants

Start Date

Oct 25, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Emergence agitation is a clinical condition in which the child experiences a variety of behavioural disturbances including crying, thrashing, and disorientation during early awakening from anaesthesia. Emergence agitation is a common challenge in children with a reported incidence of approximately 25% ranging from 10 to 80 %. Clonidine is often used off-label in paediatric anaesthesia e.g. sedation in the intensive care unit, prevention of withdrawal symptoms after long-term sedation, as premedication before induction of anaesthesia or as treatment/prevention of emergence agitation. The study is designed as a randomised, placebo-controlled clinical trial evaluating efficacy and safety of a single dose of intraoperative clonidine in children 3-12 months, including pharmacokinetics.


Eligibility

Min Age: 3 MonthsMax Age: 12 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Clonidine and a drug called Sodium chloride for people with emergence delirium. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 3 Months to 12 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGClonidine

Clonidine injection 3 mcg/kg once

DRUGSodium chloride

Sodium chloride 0.9 % injection 0.2 mL/kg once


Locations(2)

Perth Children's Hospital, Department of Anaesthesia and Pain Medicine

Perth, Nedlands, Australia

Copenhagen University Hospital, Rigshospitalet

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05091242


Related Trials